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ABSTRACT 
Introduction: Metabolic syndrome is associated with low-grade, chronic inflammation. Our 
study aimed to evaluate the effects of tocotrienols supplementation on cytokines and lipid 
profile in adults with metabolic syndrome. Methods: In a 16-week randomised, double-blind, 
placebo-controlled trial, 70 adults with metabolic syndrome aged 20-60 years were randomly 
assigned to a mixed tocotrienols group (n=35) that received 400mg/day of mixed tocotrienols 
or a placebo group (n=35) that received capsules containing soy bean oil. At baseline, week 8 
and week 16, anthropometric, body composition and blood pressure measurements were 
conducted. At baseline and week 16 only, serum levels of total cholesterol (TC) and high 
density lipoprotein (HDL)-cholesterol, plasma levels of fasting plasma glucose (FPG), 
interleukin-6 (IL-6), tumouxr necrosis factor- a (TNF-a), leptin, adiponectin and high 
sensitivity C-reactive protein were also determined. Changes in dietary intake and physical 
activity level between baseline, week 8 and week 16 were also assessed. Results: In the 
tocotrienols group, significant reductions from baseline were found in diastolic blood 
pressure (p=0.001), TC (p=0.008), LDL-cholesterol (p=0.022), HDL-cholesterol (p<0.001), 
IL-6 (p=0.024) and TNF-a (p=0.013) at week sixteen. However, the changes in the 
tocotrienols group were not significantly different from those of the placebo group. 
Conclusion: The 16-week mixed tocotrienols supplementation exerted potential beneficial 
effects on cytokines and lipid profile in adults with metabolic syndrome. The results might 
have been confounded by the physiological effects produced by the soy bean oil in the 
placebo capsule.  
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